These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1495997

  • 1. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
    Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, Calabretta B.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):7031-5. PubMed ID: 1495997
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
    Citro G, Szczylik C, Ginobbi P, Zupi G, Calabretta B.
    Br J Cancer; 1994 Mar 01; 69(3):463-7. PubMed ID: 8123474
    [Abstract] [Full Text] [Related]

  • 3. Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.
    Ho PT, Ishiguro K, Wickstrom E, Sartorelli AC.
    Antisense Res Dev; 1991 Mar 01; 1(4):329-42. PubMed ID: 1821654
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G, Negroni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B.
    Cancer Res; 1992 Aug 01; 52(15):4221-6. PubMed ID: 1638535
    [Abstract] [Full Text] [Related]

  • 5. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
    Anfossi G, Gewirtz AM, Calabretta B.
    Proc Natl Acad Sci U S A; 1989 May 01; 86(9):3379-83. PubMed ID: 2541445
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C, Rivoltini L, Parmiani G, Calabretta B, Colombo MP.
    Cancer Res; 1991 Jun 01; 51(11):2897-901. PubMed ID: 2032228
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C, Skórski T, Malaguarnera L, Hetman J, Chen ST, Calabretta B.
    Folia Histochem Cytobiol; 1996 Jun 01; 34(3-4):129-34. PubMed ID: 8967957
    [Abstract] [Full Text] [Related]

  • 8. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
    Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Ratajczak M, Beran M, Gewirtz AM.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2351-5. PubMed ID: 2006173
    [Abstract] [Full Text] [Related]

  • 9. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P, Geiser TA, Ombres D, Citro G.
    Anticancer Res; 1997 Mar 15; 17(1A):29-35. PubMed ID: 9066627
    [Abstract] [Full Text] [Related]

  • 10. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM.
    Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11823-7. PubMed ID: 1281545
    [Abstract] [Full Text] [Related]

  • 11. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D, Cucco C, Leonetti C, Citro G, D'Agnano I, Benassi M, Geiser T, Zon G, Calabretta B, Zupi G.
    Br J Cancer; 1996 Aug 15; 74(3):387-93. PubMed ID: 8695353
    [Abstract] [Full Text] [Related]

  • 12. Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
    Citro G, Ginobbi P, Szczylik C.
    Cytotechnology; 1993 Aug 15; 11 Suppl 1():S30-4. PubMed ID: 7764059
    [Abstract] [Full Text] [Related]

  • 13. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
    Tóth G, Schlammadinger J, Aradi J, Antal-Szalmás P, Sipka S, Balázs M, Kovács P, Fehér Z, Falus A.
    Cell Biol Int; 2004 Aug 15; 28(11):817-23. PubMed ID: 15563404
    [Abstract] [Full Text] [Related]

  • 14. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.
    Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R.
    Oncogene; 1992 Nov 15; 7(11):2243-8. PubMed ID: 1359494
    [Abstract] [Full Text] [Related]

  • 15. Chemical modification of ligands for cell receptors to introduce foreign compounds into the cells.
    Citro G, Ginobbi P, Candiloro A, Meloni A, Sarti P, Milani A [corrected to Meloni A].
    Dis Colon Rectum; 1994 Feb 15; 37(2 Suppl):S127-32. PubMed ID: 8313784
    [Abstract] [Full Text] [Related]

  • 16. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb.
    Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B.
    Science; 1989 Jul 14; 245(4914):180-3. PubMed ID: 2665077
    [Abstract] [Full Text] [Related]

  • 17. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
    Venturelli D, Mariano MT, Szczylik C, Valtieri M, Lange B, Crist W, Link M, Calabretta B.
    Cancer Res; 1990 Nov 15; 50(22):7371-5. PubMed ID: 2224864
    [Abstract] [Full Text] [Related]

  • 18. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro.
    Simons M, Rosenberg RD.
    Circ Res; 1992 Apr 15; 70(4):835-43. PubMed ID: 1551207
    [Abstract] [Full Text] [Related]

  • 19. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S, Skorski T, Cucco C, Nieborowska-Skorska M, Chiu CY, Lloyd D, Chen JK, Koziolkiewicz M, Calabretta B.
    Nucleic Acids Res; 1996 Apr 15; 24(8):1508-14. PubMed ID: 8628685
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C, Calabretta B.
    Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.